SARCOPENIA: NO CONSENSUS, NO DIAGNOSTIC CRITERIA, AND NO APPROVED INDICATION HOW DID WE GET HERE?
William Evans · 2024
Read SARCOPENIA: NO CONSENSUS, NO DIAGNOSTIC CRITERIA, AND NO APPROVED INDICATION HOW DID WE GET HERE? by William Evans (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11690976.txt.
Description
William Evans asks how sarcopenia, the age-related loss of muscle, reached a state with no agreed definition, no diagnostic criteria, and no approved drug, in a symposium paper from 2024. Muscle is far more than a motor: it disposes of blood sugar, drives resting metabolism, supports bone, and stores amino acids for hard times.
Losing muscle therefore feeds chronic disease, disability, and death, and drug makers have chased muscle-building therapies for decades. Yet none has won approval for this condition. The symposium sets out to explain the stall. Science on muscle protein control has leapt ahead, the author notes, while the field's basic terms stayed unsettled. The piece frames the talks that follow on why translation into care has failed.
Catalog record
| CREATOR | William Evans |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |